loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Sotorasib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 American Pacific Corporation (1)

02 Catalent Micron Technologies, Inc. (1)

03 Sigma Aldrich Corporation (1)

filter

01 Sotorasib (3)

filter

01 U.S.A (3)

URL Supplier Web Content
Sotorasib
POWDER (1kg/kg)
BULK INGREDIENT
50683-0573
2021-11-17
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Sotorasib
POWDER (1kg/1)
DRUG FOR FURTHER PRO...
69988-0057
2020-03-06
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Sotorasib
POWDER (1kg/kg)
BULK INGREDIENT
58272-065
2021-05-28
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 2296729-00-3 / Sotorasib API manufacturers, exporters & distributors?

Sotorasib manufacturers, exporters & distributors 1

33

PharmaCompass offers a list of Sotorasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sotorasib manufacturer or Sotorasib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sotorasib manufacturer or Sotorasib supplier.

PharmaCompass also assists you with knowing the Sotorasib API Price utilized in the formulation of products. Sotorasib API Price is not always fixed or binding as the Sotorasib Price is obtained through a variety of data sources. The Sotorasib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Sotorasib

Synonyms

Amg-510, Amg510, 2296729-00-3, Lumakras, Amg-510 racemate, Amg 510

Cas Number

2296729-00-3

Unique Ingredient Identifier (UNII)

2B2VM6UC8G

About Sotorasib

Sotorasib is an orally available inhibitor of the specific KRAS mutation, p.G12C, with potential antineoplastic activity. Upon oral administration, sotorasib selectively targets, binds to and inhibits the activity of the KRAS p.G12C mutant. This may inhibit growth in KRAS p.G12C-expressing tumor cells. The KRAS p.G12C mutation is seen in some tumor cell types and plays a key role in tumor cell proliferation.

Sotorasib Manufacturers

A Sotorasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sotorasib, including repackagers and relabelers. The FDA regulates Sotorasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sotorasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sotorasib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Sotorasib Suppliers

A Sotorasib supplier is an individual or a company that provides Sotorasib active pharmaceutical ingredient (API) or Sotorasib finished formulations upon request. The Sotorasib suppliers may include Sotorasib API manufacturers, exporters, distributors and traders.

click here to find a list of Sotorasib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Sotorasib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sotorasib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Sotorasib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Sotorasib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Sotorasib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sotorasib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Sotorasib suppliers with NDC on PharmaCompass.

Sotorasib Manufacturers | Traders | Suppliers

Sotorasib Manufacturers, Traders, Suppliers 1
20

We have 3 companies offering Sotorasib

Get in contact with the supplier of your choice:

  1. American Pacific Corporation
  2. Catalent Pharma Solutions
  3. Sigma-Aldrich Corporation
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY